Emergent BioSolutions Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Emergent BioSolutions Inc. on March 4, 2011, covering events that occurred on February 28, 2011. The filing details executive compensation adjustments, including cash bonuses, salary updates, and equity awards approved by the Compensation Committee.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics. It focuses exclusively on executive compensation figures.
- Cash Bonuses Awarded (Feb 28, 2011): R. Don Elsey ($177,060), Kyle W. Keese ($185,900), Stephen Lockhart ($90,806).
- 2011 Annualized Base Salaries (Effective Jan 1, 2011): Fuad El-Hibri ($669,394), Daniel J. Abdun-Nabi ($466,710), R. Don Elsey ($368,430), Kyle W. Keese ($346,133), Stephen Lockhart ($279,989).
- 2011 Target Bonus Percentages: Fuad El-Hibri (75%), Daniel J. Abdun-Nabi (55%), R. Don Elsey (50%), Kyle W. Keese (50%), Stephen Lockhart (40%).
Material Changes and Equity Awards
The Compensation Committee approved grants of stock options and restricted stock units (RSUs) to be issued on the third full business day following the release of fiscal year 2010 results. The number of shares will be determined based on specific cash values assigned to each executive.
| Executive | Option/RSU Cash Value Basis |
|---|---|
| Fuad El-Hibri | $738,300 |
| Daniel J. Abdun-Nabi | $386,550 |
| R. Don Elsey | $135,400 |
| Kyle W. Keese | $195,000 |
| Stephen Lockhart | $50,700 |
Terms: Options have an exercise price equal to the fair market value on the Grant Date and vest one-third annually over three years, expiring on the seventh anniversary. RSUs have a purchase price of $0.001 per share, satisfied by continued employment, and vest one-third annually over three years.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operations, or discussion of risks and contingencies. The document is strictly a disclosure of compensatory arrangements.
Key Facts for Investor Verification
- Verify the exact Grant Date for the equity awards, as it depends on the release of fiscal year 2010 results.
- Confirm the total number of shares issued for options and RSUs once the Grant Date stock price is known.
- Review the company's 2006 Stock Incentive Plan to understand the full terms and conditions of the awards.
- Note that the filing does not disclose the company's overall financial performance for the period.